Cardiology

Digital screening more than doubled the detection rate of treatment-relevant AF in both phases of eBRAVE-AF trial.

An analysis of the FIDELITY program from ESC Congress 2022 details an 11% reduction in risk of all-cause mortality and a 25% reduction in risk of sudden cardiac death among patients with type 2 diabetes and chronic kidney disease.

Targeting a mean arterial blood pressure of 77 mm Hg or 63 mm Hg was not associated with significantly different percentages of patients dying or having severe disability or coma.

SGLT2 inhibitors reduce the risk of hospitalization for heart failure, extend survival, and improve overall health status, irrespective of ejection fraction, in patients with heart failure.

Results of a trial assessing the impact of universal subclinical CVD screenings found increased screenings did not significantly reduce the risk of all-cause mortality in men aged 65-74 years over the next 5 years.

The treatment strategy led to lower risk of major adverse cardiovascular events than usual care in older patients with recent myocardial infarction.

The risk of coronary heart disease and stroke decreased by 22% for every 1 point rise in the sleep score at baseline.

Regardless of frailty status, edoxaban 15 mg was associated with significantly reduced incidence of the study outcomes compared with placebo.

Pharmacovigilance studies sifting through FDA adverse event reports confirm ocular side effects from PCSK9 inhibitors are infrequent and minor.

Vaccine-associated myocarditis was largely restricted to men younger than 40 years, according to the new findings.

The investigational therapy is being evaluated in a phase 2 study for the reduction in risk of major thrombotic cardiovascular events in patients with ESRD on hemodialysis.

An observational study of more than 300,000 with type 2 diabetes from Denmark suggests short-term use of NSAIDs was linked to a more than 40% increase in the likelihood of a first-time heart failure hospitalization.

The scientific statement reviews symptoms associated with ACS, heart failure, valvular disorders, stroke, rhythm disorders, and peripheral vascular disease.

A study of 202 patients in Taiwan suggests use of a video motion analysis using video captured from a smartphone could help identify carotid artery stenosis.

An analysis suggests reducing the mean daily sodium intake from 11 grams to 10 grams per day could reduce blood pressure and contribute to reductions in risk of cardiovascular and stroke events.

Results of the HOME BP study suggest a linked smartphone application combined with standard blood pressure monitoring did not result in superior blood pressure reductions than a standard approach.

A presentation by Christine Schumacher, PharmD, and Elizabeth Van Dril, PharmD, at ADCES examines the current state of heart failure management in patients with diabetes.

On August 11, the American College of Chest Physicians (CHEST) released 44 new evidence-based recommendations in their new guidelines for perioperative management of antithrombotic therapy, which were published with the intention of replacing the 2012 guidelines on the subject.

A systematic review and meta-analysis provide an overview of the potential improvements in cardiometabolic health profile, including changes in HDL-C, LDL-C, and triglycerides, observed after patients with obstructive sleep apnea have undergone soft-tissue surgery.

A systematic review and meta-analysis from SSaSS investigators provide further insight into the reductions in blood pressure observed with use of a salt substitute, as well as the impact of use on overall risk of mortality and mortality from cardiovascular-specific causes.

The agency has taken new action against Juul while experts worry about youth addiction and health impacts. But the e-cigarette market has been already well established in the US.

Called the DiaBeats algorithm, new research suggests leveraging the machine learning-based algorithm, combined with ECG recordings, could help predict increased risk of developing prediabetes and type 2 diabetes.

New research suggests there was a 53% greater 5-year risk of cardiovascular disease in men with type 2 diabetes who received a GnRH agonist for prostate cancer compared with their counterparts who did not receive GnRH agonists.

An analysis of patient data from the Chronic Renal Insufficiency Cohort Study suggests increased levels of serum aldosterone were associated with an increased risk of chronic kidney disease progression.

Early time-restricted eating was more effective for losing weight than eating over a window of ≥12 hours, but did not affect body fat.